A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian Cancer

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

Low-Grade Serous Ovarian Cancer

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Emory Winship Cancer Institute, Atlanta, Georgia, United States

    Contact: Study coordinator (Beryl Manning-Geist, MD) · 404-778-3401
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States

    Contact: Study coordinator (Rachel Grisham, MD) · 646-888-4653
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States

    Contact: Study coordinator (Rachel Grisham, MD) · 646-888-4653
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

    Contact: Study coordinator (Rachel Grisham, MD) · 646-888-4653
  • Memorial Sloan Kettering Suffolk -Commack (Limited Protocol Activities), Commack, New York, United States

    Contact: Study coordinator (Rachel Grisham, MD) · 646-888-4653
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities), East White Plains, New York, United States

    Contact: Study coordinator (Rachel Grisham, MD) · 646-888-4653
  • Memorial Sloan Kettering Cancer Center, New York, New York, United States

    Contact: Study coordinator (Rachel Grisham, MD) · 646-888-4653
    Contact: Study coordinator (Chrisann Kyi, MD) · 646-888-4221
    Contact: Principal Investigator (Rachel Grisham, MD)
  • Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York, United States

    Contact: Study coordinator (Rachel Grisham, MD) · 646-888-4653
מובילי המחקר
  • Rachel Grisham, MD

    Principal Investigator

    Memorial Sloan Kettering Cancer Center